XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity and Equity Incentive Plan (Tables)
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of Common Stock Reserved for Future Issuance
As of September 30, 2023, the Company had the following shares of common stock reserved for future issuance under its equity incentive plan and employee share purchase plan:
Stock options outstanding7,157,218 
Restricted stock outstanding6,763,380 
Remaining shares available for future grant under 2021 Equity Incentive Plan(1)
4,107,198 
Remaining shares available for future issuance under ESPP(2)
1,895,121 
Total shares of common stock reserved as of September 30, 2023
19,922,917 
(1)Includes the automatic annual increase of 2,377,740 additional shares under the Company’s 2021 Equity Incentive Plan (“2021 Plan”) on January 1, 2023.
(2)Includes the automatic annual increase of 475,548 additional shares under the Company’s ESPP on January 1, 2023.
Schedule of Repurchase Agreements
The following table presents certain information regarding shares repurchased during the periods presented:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Number of shares repurchased3,416,682 — 7,517,260 1,531,209 
Average price per share, including commissions$7.32 $— $7.88 $14.24 
Total repurchase costs, including commissions (in millions)$25.0 $— $59.2 $21.8 
Schedule of Stock Options
A summary of stock option activity and related information is as follows:
Options Outstanding
Number
of
Shares
Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual Life
(in years)		Aggregate
Intrinsic Value
(in thousands)
Balance as of December 31, 2022
7,756,680 $6.96 
Granted
— — 
Anti-dilution adjustment(1)
389,037 1.92 
Exercised(733,884)1.93 $4,415 
Cancelled and forfeited(254,615)19.14 
Balance as of September 30, 2023
7,157,218 $5.91 5.09$23,721 
Vested and exercisable6,289,769 $4.89 4.82$22,948 
(1)Represents the incremental increase in the number of shares issuable upon vesting of options outstanding prior to the Special Dividend pursuant to the anti-dilution adjustment.
Schedule of RSU Activity
A summary of RSU activity and related information is as follows:
RSUs Outstanding
Number of
Shares
Weighted-Average
Grant Date
Fair Value
Unvested balance as of December 31, 2022
5,134,934 $14.37 
Granted2,771,342 8.42 
Anti-dilution adjustment(1)
950,208 12.43 
Vested(1,727,598)14.61 
Cancelled and forfeited(996,281)13.47 
Unvested balance as of September 30, 2023
6,132,605 $11.46 
(1)Represents the incremental increase in the number of shares issuable upon vesting of RSUs outstanding prior to the Special Dividend pursuant to the anti-dilution adjustment.
Schedule of Share-Based Compensation Expense by Line Item in the Consolidated Statements of Operations
The stock-based compensation expense by line item in the condensed consolidated statements of operations is summarized as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Cost of revenue
Subscription and other platform$638 $849 $2,132 $2,540 
Professional services123 165 419 505 
Total cost of revenue761 1,014 2,551 3,045 
Sales and marketing3,693 3,597 10,305 10,986 
Research and development2,332 2,019 6,716 5,925 
General and administrative4,779 3,273 13,719 9,152 
Total stock-based compensation expense$11,565 $9,903 $33,291 $29,108 
Schedule of Unrecognized Stock-Based Compensation Expenses
The following table presents the unrecognized stock-based compensation expense and weighted-average recognition periods as of September 30, 2023 (in thousands, except years):
Stock Option
Restricted Stock
ESPP
Unrecognized stock-based compensation expense$14,427 $58,991 $46 
Weighted-average amortization period1.47 years2.24 years0.13 years